Cargando…
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies
Targeting concomitantly cholinesterase (ChEs) and monoamine oxidases (MAO-A and MAO-B) is a key strategy to treat multifactorial Alzheimer's disease (AD). Moreover, it is reported that the expression of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) is increased significantly in the brain of A...
Autores principales: | Javed, Muhammad Aamir, Bibi, Saba, Jan, Muhammad Saeed, Ikram, Muhammad, Zaidi, Asma, Farooq, Umar, Sadiq, Abdul, Rashid, Umer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366597/ https://www.ncbi.nlm.nih.gov/pubmed/36105972 http://dx.doi.org/10.1039/d2ra04183a |
Ejemplares similares
-
Design, Synthesis, and Bioevaluation of Indole Core
Containing 2-Arylidine Derivatives of Thiazolopyrimidine as
Multitarget Inhibitors of Cholinesterases and Monoamine Oxidase A/B
for the Treatment of Alzheimer Disease
por: Shahid Nadeem, Muhammad, et al.
Publicado: (2022) -
N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2022) -
Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022) -
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
por: Ramsay, Rona R., et al.
Publicado: (2017) -
Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives
por: Ahmad, Ashfaq, et al.
Publicado: (2020)